InvestorsHub Logo
Followers 91
Posts 17876
Boards Moderated 0
Alias Born 09/06/2006

Re: 10baggerz post# 340618

Friday, 12/18/2020 4:51:40 PM

Friday, December 18, 2020 4:51:40 PM

Post# of 723359

But to your point, if the trail was a complete and utter failure, NWBO would likely NOT publish the results in a scientific journal.


NWBO might not.Other companies do though. Even small biotechs.

It is expected that results are published for any significant trial, regardless of outcome.

The failed ACT-IV trial of CLDX's P3 of Rindopepimut in glioblastoma was published in The Lancet with over 100 authors.

I would note that every trial on ATL's list of comps was published, yet other than Optune all failed.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News